Physician

James Bresee, M.D.

According to 2025 Medicare claims, James Bresee, M.D. (NPI: 1730484544) practices urology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Washington, OR. This provider's primary affiliated billing organization is NORTHWEST UROLOGY, LLC (NPI: 1629461397; TIN: 47-3238987) and primary practice location at 97225-6683.

Bresee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 458 traditional Medicare patients, billed 8,251 HCPCS/CPT codes, and received $363,566 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 2,322 prescription claims across 707 beneficiaries totaling $298,503 in drug costs, led by Gemtesa (Vibegron). DME data shows 116 claims. Open Payments data shows 119 records totaling $4,654. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $63,136 to $363,566. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $77,528 to $298,503. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $131 and ending at $473.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	130	7,004	$63,136
2016	243	4,426	$107,922
2017	302	4,905	$167,677
2018	304	5,829	$173,943
2019	391	10,989	$305,004
2020	358	14,725	$471,239
2021	341	8,541	$307,367
2022	339	6,185	$256,307
2023	428	8,694	$417,568
2024	458	8,251	$363,566

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	292	1,940	$77,528
2016	370	1,443	$74,215
2017	365	1,389	$83,930
2018	443	1,887	$153,723
2019	508	2,129	$201,200
2020	500	2,207	$456,791
2021	485	1,684	$330,042
2022	491	1,505	$277,660
2023	577	1,868	$282,172
2024	707	2,322	$298,503

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	28	$3,299
2017	N/R	13	$4,323
2018	N/R	17	$5,246
2019	N/R	23	$7,828
2020	N/R	111	$35,097
2021	N/R	98	$29,446
2022	11	91	$28,891
2023	12	103	$44,916
2024	11	116	$62,540

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	167	218	$173
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	161	161	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	339	608	$97
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	314	406	$12
51798	Ultrasound measurement of bladder capacity after voiding	396	699	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gemtesa	Vibegron	135	9,807	$152,817
Myrbetriq	Mirabegron	55	4,426	$62,150
Tamsulosin Hcl	Tamsulosin Hcl	755	65,854	$10,879
Finasteride	Finasteride	810	69,640	$9,829
Testosterone	Testosterone	19	865	$3,513

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	47	$42,376
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	11	58	$19,691
A4332	Lubricant, individual sterile packet, each	N	N/R	11	$473

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	119	$4,654	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Bresee, M.D.?

Tedicare shows public-source Medicare data for James Bresee, M.D. (NPI 1730484544), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Bresee, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Bresee, M.D.?

James Bresee, M.D. is linked to NORTHWEST UROLOGY, LLC (billing NPI 1629461397) in the available physician profile data.

Does James Bresee, M.D. have Open Payments data?

James Bresee, M.D. has 119 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.